These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33913629)

  • 21. Omitted Author in the Article by Bernstein et al (Arthritis Rheumatol, November 2020).
    Arthritis Rheumatol; 2021 Apr; 73(4):720. PubMed ID: 33769720
    [No Abstract]   [Full Text] [Related]  

  • 22. Errors in Table 3 of the Article by Domsic et al (Arthritis Rheumatol, April 2016).
    Arthritis Rheumatol; 2016 Nov; 68(11):2751. PubMed ID: 27785909
    [No Abstract]   [Full Text] [Related]  

  • 23. Omission of Author Name From the Article by Wilkinson et al (Arthritis Rheumatol, August 2017).
    Arthritis Rheumatol; 2018 Oct; 70(10):1596. PubMed ID: 30260595
    [No Abstract]   [Full Text] [Related]  

  • 24. Omission of Senior Authorship Statement in the Article by Gilis et al (Arthritis Rheumatol, December 2019).
    Arthritis Rheumatol; 2020 Sep; 72(9):1513. PubMed ID: 33448687
    [No Abstract]   [Full Text] [Related]  

  • 25. Amended 95% confidence intervals in tables in the article by Jani et al (Arthritis Rheumatol, August 2015).
    Arthritis Rheumatol; 2015 Nov; 67(11):3096. PubMed ID: 26508467
    [No Abstract]   [Full Text] [Related]  

  • 26. Incorrect Data in Tables and Omission of Author Name in the Article by Bowman et al (Arthritis Rheumatol, July 2017).
    Arthritis Rheumatol; 2020 Oct; 72(10):1748. PubMed ID: 33460295
    [No Abstract]   [Full Text] [Related]  

  • 27. Incorrect Disclosure Information Added for Author Neogi in the Article by Choi et al (Arthritis Rheumatol, November 2018).
    Arthritis Rheumatol; 2018 Dec; 70(12):2086. PubMed ID: 30485730
    [No Abstract]   [Full Text] [Related]  

  • 28. Financial Disclosure Information on One Author in the Article by Cartin-Ceba et al (Arthritis Rheumatol, June 2016).
    Arthritis Rheumatol; 2016 Sep; 68(9):2140. PubMed ID: 27558405
    [No Abstract]   [Full Text] [Related]  

  • 29. Incorrect Spelling of Author's First Name in the Article by Kass et al (Arthritis Rheumatol, March 2020).
    Arthritis Rheumatol; 2020 Apr; 72(4):597. PubMed ID: 32227631
    [No Abstract]   [Full Text] [Related]  

  • 30. Missing Disclaimer Information in the Title-Page Footnotes of the Article by Rims et al (Arthritis Rheumatol, April 2019).
    Arthritis Rheumatol; 2019 Jun; 71(6):907. PubMed ID: 31132227
    [No Abstract]   [Full Text] [Related]  

  • 31. Two NIH Grants Omitted From Grant Support Statement in the Article by Kalampokis et al (Arthritis Rheumatol, January 2017).
    Arthritis Rheumatol; 2017 Oct; 69(10):2080. PubMed ID: 28960941
    [No Abstract]   [Full Text] [Related]  

  • 32. Errors in Two Sentences in the Patients and Methods Section of the Article by Duarte-García et al (Arthritis Rheumatol, September 2019).
    Arthritis Rheumatol; 2020 Apr; 72(4):597. PubMed ID: 32227632
    [No Abstract]   [Full Text] [Related]  

  • 33. Errors in the Format of the Global Pain Score (Visual Analog Scale) in the Article by Roman-Blas et al (Arthritis Rheumatol, January 2017).
    Arthritis Rheumatol; 2017 Oct; 69(10):2080. PubMed ID: 28960940
    [No Abstract]   [Full Text] [Related]  

  • 34. Incorrect Academic Degree and/or Affiliation Information for Two Authors in the Article by Rodríguez-Carrio et al (Arthritis Rheumatol, March 2021).
    Arthritis Rheumatol; 2021 May; 73(5):799. PubMed ID: 33913628
    [No Abstract]   [Full Text] [Related]  

  • 35. Incorrect Frequency of Belimumab Infusions Reported in the Article by Atisha-Fregoso et al (Arthritis Rheumatol, January 2021).
    Arthritis Rheumatol; 2021 Dec; 73(12):2356. PubMed ID: 34890126
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse Events of Special Interest Incorrectly Referred to As Serious Adverse Events of Special Interest in the Article by Chatham et al (Arthritis Rheumatol, May 2021).
    Arthritis Rheumatol; 2021 Aug; 73(8):1570. PubMed ID: 34329543
    [No Abstract]   [Full Text] [Related]  

  • 37. Minus Signs Inadvertently Inserted for Two 95% Confidence Interval Values in the Article by Steen Pettersen et al (Arthritis Rheumatol, July 2019).
    Arthritis Rheumatol; 2021 Nov; 73(11):2043. PubMed ID: 34731537
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterozygosity of the 721.221-B*51:01 Cell Line Used in the Study by Guasp et (Arthritis Rheumatol, February 2016).
    Arthritis Rheumatol; 2017 Mar; 69(3):686. PubMed ID: 28239991
    [No Abstract]   [Full Text] [Related]  

  • 39. Do Not Disregard the Use of Chondroitin Sulfate For Knee OA: Comment on the Article by Kolasinski et al.
    Velasco J
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1664-1665. PubMed ID: 32770734
    [No Abstract]   [Full Text] [Related]  

  • 40. Omission of Fifth Author in the Reply Letter by Mathian et al (Arthritis Rheumatol, January 2020).
    Arthritis Rheumatol; 2020 Apr; 72(4):597. PubMed ID: 32227633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.